CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Administration of an 8% crystalline L-amino acid solution with high concentrations of branched chain amino acids.other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04886973
NCT04886973N/ACompleted

Effect of Insulin Resistance on Branched Chain Amino Acid Metabolism.

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran·interventional·Posted May 14, 2021·Updated Aug 2, 2022

In Brief

A clinical study evaluating Administration of an 8% crystalline L-amino acid solution with high concentrations of branched chain amino acids. for Obesity and Insulin Resistance. Completed, enrolled 40 participants across 1 site.

Detailed Summary

It has been observed that subjects with obesity and insulin resistance have higher concentrations of branched chain amino acids in plasma or serum. However, this association has been established under fasting conditions, so they only give information about a metabolic state and do not reflect the dynamics and flexibility of the metabolism of these amino acids in the absence or presence of insulin resistance. The main aim of this study is to compare the catabolism of branched chain amino acids and their keto acids in subjects with and without insulin resistance, after the infusion of an amino acid solution with high concentration of the branched chain amino acids, leucine, valine, and isoleucine. The results of this project will allow the investigators to understand the dynamics of the branched chain amino acids and their derivatives, and its relationship with insulin resistance, which could eventually be used to design nutritional strategies to treat insulin resistance and thus, delay the development of type 2 diabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesMexico
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 14, 2021
Enrollment StartMar 31, 2022
Primary CompletionJul 29, 2022
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 5.1 years ago

Interventions

Administration of an 8% crystalline L-amino acid solution with high concentrations of branched chain amino acids.other

Intravenous administration of 8% crystalline L-amino acids with high concentrations of branched chain amino acids.